Iuliu Hațieganu University of Medicine and Pharmacy / Universitatea de Medicină și Farmacie "Iuliu Hațieganu" (UMF Cluj)

University / College


Location: Cluj-Napoca, Romania (RO) RO

ISNI: 0000000405715814

ROR: https://ror.org/051h0cw83

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Cardiovascular autonomic regulation correlates with cognitive performance in patients with a history of traumatic brain injury (2023) Wang R, Muresanu D, Hösl K, Hilz MJ Journal article Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient? (2022) Kegyes D, Constantinescu C, Vrancken L, Rasche L, Gregoire C, Tigu B, Gulei D, et al. Journal article, Review article Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort (2022) Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, et al. Journal article Persistent inflammation in systemic sclerosis is strongly associated with mortality: a EUSTAR database analysis (2022) Guler SA, Sarbu A, Stadler O, Allanore Y, Bernardino , Distler J, Gabrielli A, et al. Conference contribution PERSISTENT INFLAMMATION IN SYSTEMIC SCLEROSIS IS STRONGLY ASSOCIATED WITH SEVERE DISEASE AND MORTALITY: AN ANALYSIS FROM THE EUSTAR DATABASE (2022) Sarbu AC, Guler S, Stadler O, Allanore Y, Bernardino V, Distler J, Gabrielli A, et al. Conference contribution Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline (2022) Deprez PH, Moons LMG, O'Toole D, Gincul R, Seicean A, Pimentel-Nunes P, Fernandez-Esparrach G, et al. Journal article EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS: A PROPENSITY SCORE CONTROL MATCHED OBSERVATIONAL STUDY OF THE EUSTAR COHORT (2021) Kuster S, Jordan S, Elhai MD, Held U, Steigmiller K, Bruni C, Iannone F, et al. Conference contribution Overview of the side-effects of FDA-and/or EMA-approved targeted therapies for the treatment of hematological malignancies (2020) Constantinescu C, Pasca S, Zimta AA, Tat T, Rus I, Teodorescu P, Iluta S, et al. Journal article Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies? (2020) Constantinescu C, Pasca S, Tat T, Teodorescu P, Vlad C, Iluta S, Dima D, et al. Journal article, Review article CD19-targeted, Raman tagged gold nanourchins as theranostic agents against acute lymphoblastic leukemia (2019) Tatar AS, Jurj A, Tomuleasa C, Florea A, Berindan-Neagoe I, Cialla-May D, Popp J, et al. Journal article
‹ 1 2 3 ›